Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
PaperCitations, authors & open-access status
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,675 citations, 2011 year and green oa status.
1,675
Citations
2011
Year
green
OA Status